SLC35F5

Across TCGA pan-cancer cohorts, SLC35F5 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated SLC35F5 data layer compared with 28 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SLC35F5 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLC35F5 expression acts as an unfavorable survival marker, although some lineages such as UCEC and GBM show a favorable association.

LUAD, PDAC, and UCEC are the cancer types where SLC35F5 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.547	1.000	.009	20	view →
PDAC	DFS	Quartile	All	0.570	0.850	.004	18	view →
UCEC	DFS	Tertile	II,III,IV	0.943	0.360	.024	8	view →
LSCC	OS	Median	III,IV	0.473	0.873	.031	6	view →
GBM	DFS	Tertile	All	0.804	0.413	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

SLC35F5–LUAD (DFS)

Open the LUAD breakdown →